Tumor heterogeneity has been known for a while but quantifying heterogeneity is still a challenge. NGS is the method of choice in the analysis of tumor heterogeneity, however, there are some inherent challenges associated with it. These include false positives, gaps in the gene due to overrepresentation and incomplete representation of low-frequency transcripts – all contributing to an inaccurate picture. Conventional library prep strategies for NGS are based on PCR, which introduces sequence-based bias and amplification noise, leading to these inaccuracies.
In this webinar, we will cover
Cancer
Gene Expression
Mass Cytometry
Dna
Cancer Research
T-Cells
Biomarkers
Immunotherapeutics
Research
Oncology
Molecular Genetics
Gene Sequencing
Personalized Medicine
Drug Discovery
Cell Culture
Europe100%
Website Visitors100%
Student100%
Academic Institution100%